Also see: Jones Group, CB&I: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

STOCK COMMENTS / EPS CHANGES

Covidien

(COV)

estimates, target were raised at Goldman Sachs. Shares now seen reaching $60. Estimates also increased, as the company is buying back more stock, Goldman said. Buy rating.

CVS Caremark

(CVS) - Get Report

estimates were increased through 2012 at JMP Securities. Improved PBM execution in 2012 and considerable cash flow deployment potential, JMP said. Market Outperform rating.

Donaldson

(DCI) - Get Report

estimates were increased through 2013 at Credit Suisse. Company is realizing higher margins, Credit Suisse said. Outperform rating and $67 price target.

Express Scripts

(ESRX)

estimates, target lowered at JMP Securities. Shares now seen reaching $69. Adjusting model to account for more conservative volume expectations, JMP said. Market Outperform rating.

Starwood Hotels

(HOT)

numbers reduced at Credit Suisse. Shares now seen reaching $64. Estimates also cut, given macro growth concerns, Credit Suisse said. Outperform rating.

Juniper

(JNPR) - Get Report

estimates, target cut at UBS. Shares now seen reaching $24. Estimates also lowered on tough macro, and ramp of new products still unclear, UBS said. Neutral rating.

Medco

(MHS)

estimates were lowered through 2012 at JMP Securities. Lowered expectations for net-new business in 2012, JMP said. Market Outperform rating.

Nokia

(NOK) - Get Report

estimates were raised at Oppenheimer through 2012. Surprisingly strong demand in low-end/feature phones, Oppenheimer said. Maintain Market Perform rating.

PVH

(PVH) - Get Report

estimates raised at Piper Jaffray through 2011. Continued strength led by Calvin Klein, Piper Jaffray said. Maintain $75 price target and Overweight rating.

End of report.

This article was written by a staff member of TheStreet.